A RANDOMIZED CONTROLLED PHASE II CLINICAL TRIAL OF MODULATION OF INTER-261095130

$0N01FY2006CANIH

University Of Wisconsin

Investigators

George Wildingcontact

View original record on NIH RePORTER →